JYMed Technology Co., Ltd. zoo siab tshaj tawm tias nws cov khoom lag luam, Tirzepatide, tau ua tiav daim ntawv sau npe Tshuaj Yeeb Tshuaj (DMF) nrog US FDA (DMF Number: 040115) thiab tau txais FDA Daim Ntawv Pom Zoo rau Lub Yim Hli 2, 2024.
Kev tsim khoom loj nrog ruaj khov zoo
Raws li JYMed Technology tus thawj coj loj, kev tsim khoom ntau ntawm Tirzepatide Active Pharmaceutical Ingredient (API) tuaj yeem ncav cuag qib kilogram. Cov khoom siv ntau lawm yog ruaj khov thiab tsis tu ncua, nrog qhov sib txawv me me ntawm cov khoom siv, kom ntseeg tau zoo ib yam.
Cov txiaj ntsig tseem ceeb ntawm Glucose thiab Lipid Reduction
Tirzepatide yog lub ntiaj teb thawj zaug pom zoo ib zaug ib lub lim tiam GIP / GLP-1 receptor agonist. Raws li ib tug dual receptor agonist, nws muaj peev xwm ib txhij khi thiab qhib ob lub qabzib-nyob ntawm insulinotropic polypeptide (GIP) receptor thiab GLP-1 receptor nyob rau hauv tib neeg lub cev. Ntxiv nrog rau kev txo qis cov piam thaj, nws txo qis kev noj zaub mov, lub cev hnyav, thiab cov rog, thiab tswj kev siv lipid. Tshaj li nws cov txiaj ntsig tseem ceeb ntawm kev txo cov piam thaj thiab txo qhov hnyav, pab pawg neeg soj ntsuam los ntawm SURPASS series ntawm cov kev tshawb fawb tau pom tias Tirzepatide kuj tseem txhim kho cov ntsuas metabolic xws li ntshav siab, ntshav lipids, BMI, thiab lub duav ncig.
Multinational Approvals thiab Promising Prospects
Raws li cov ntaub ntawv tseem ceeb, Mounjaro txo qis ntshav qab zib tau pom zoo thawj zaug los ntawm US FDA thaum lub Tsib Hlis 2022 rau kev kho cov neeg laus uas muaj ntshav qab zib hom 2. Tom qab ntawd nws tau txais kev pom zoo hauv EU, Nyiv, thiab lwm thaj chaw. Thaum Lub Kaum Ib Hlis 2023, FDA kuj tau pom zoo rau qhov poob phaus hauv qab lub npe Zepbound. Thaum lub Tsib Hlis 2024, nws tau nkag mus hauv Suav lag luam zoo. Muab nws cov ntawv thov dav dav thiab cov ntaub ntawv tshawb fawb muaj zog, Tirzepatide tau dhau los ua ib qho tseem ceeb tshaj plaws peptide tshuaj niaj hnub no. Nws cov kev muag khoom tau mus txog $ 5.163 nphom hauv 2023, thiab thawj peb lub hlis twg ntawm 2024 ib leeg pom kev muag khoom ntawm $ 2.324 billion, ua rau pom qhov kev loj hlob txaus ntshai.
Hais txog JYMed
Shenzhen JYMed Technology Co., Ltd. (tom qab no hu ua JYMed) tau tsim nyob rau xyoo 2009, tshwj xeeb hauv kev tshawb fawb, kev tsim kho, kev tsim khoom, thiab kev muag khoom ntawm peptides thiab cov khoom lag luam peptide. Nrog rau ib lub chaw tshawb fawb thiab peb lub hauv paus loj tshaj plaws, JYMed yog ib qho ntawm cov neeg tsim khoom loj tshaj plaws ntawm cov tshuaj lom neeg peptide APIs hauv Suav teb. Lub tuam txhab cov tub ntxhais R & D pab neeg khav theeb dhau 20 xyoo ntawm kev paub hauv kev lag luam peptide thiab tau ua tiav FDA kev tshuaj xyuas ob zaug. JYMed qhov kev ua haujlwm zoo thiab muaj txiaj ntsig peptide industrialization muaj cov neeg siv khoom ntau yam kev pabcuam, suav nrog kev txhim kho thiab tsim cov tshuaj peptides, kws kho tsiaj peptides, tshuaj tua kab mob peptides, thiab tshuaj pleev ib ce peptides, nrog rau kev sau npe thiab kev txhawb nqa.
Kev Ua Lag Luam Loj
1.Nyob hauv thiab thoob ntiaj teb kev sau npe ntawm peptide APIs
2. Veterinary thiab cosmetic peptides
3.Kev cai peptides thiab CRO, CMO, OEM kev pabcuam
4.PDC tshuaj (peptide-radionuclide, peptide-me me molecule, peptide-protein, peptide-RNA)
Ntxiv rau Tirzepatide, JYMed tau xa cov ntaub ntawv sau npe nrog FDA thiab CDE rau ob peb lwm yam khoom API, suav nrog cov tshuaj GLP-1RA cov chav kawm nrov tam sim no xws li Semaglutide thiab Liraglutide. Cov neeg siv khoom yav tom ntej uas siv JYMed cov khoom yuav tuaj yeem xa ncaj qha rau tus lej sau npe CDE lossis DMF cov ntaub ntawv tus lej thaum xa daim ntawv thov sau npe rau FDA lossis CDE. Qhov no yuav txo tau lub sij hawm xav tau rau kev npaj cov ntaub ntawv thov, nrog rau lub sij hawm ntsuam xyuas thiab nqi ntawm cov khoom tshuaj xyuas.
Tiv tauj peb
Shenzhen JYMed Technology Co., Ltd.
Chaw nyob:8th & 9th Floors, Tsev 1, Shenzhen Biomedical Innovation IndustrialChaw ua si, No. 14 Jinhui Road, Kengzi District, Pingshan District, Shenzhen
Xov tooj:+86 755-26612112
Lub Vev Xaib: http://www.jymedtech.com/
Post lub sij hawm: Aug-12-2024